Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

New approach to treating autoimmune disease offered by Weizmann scientists

In autoimmune diseases, the immune system turns against the body's own tissues and organs, wreaking havoc and destruction for no apparent reason. Partly because the origins of these diseases are so obscure, no effective treatment exists, and the suffering they inflict is enormous.

2 Jun 2008

New genetic mutations involved in inflammatory intestinal disorders discovered

The discovery of new genetic mutations involved in inflammatory intestinal disorders could lead to a better understanding of these common conditions, two scientists told the annual conference of the European Society of Human Genetics today (Monday 2 June).

2 Jun 2008

Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s

The prevalence of pre-cancerous masses in the colon is the same for average-risk patients who are 40 to 49 years of age and those who are 50 to 59 years of age, reports a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

2 Jun 2008

Tuberculosis not the only risk from new immunological drugs

A new survey cautions physicians that drugs commonly prescribed for patients suffering from immunological disorders such as rheumatoid arthritis and inflammatory bowel disease may carry risks of serious infections other than the known risk of tuberculosis. The survey published is in the June 1 issue of Clinical Infectious Diseases, currently available online.

20 May 2008

Role of genetic components of dendritic cells could lead to more effective drugs

For the first time, researchers from the University of Pittsburgh School of Medicine have identified genetic components of dendritic cells that are key to asthma and allergy-related immune response malfunction. Targeting these elements could result in more effective drugs to treat allergic disorders and asthma, according to a study reported in the May edition of the journal Nature Medicine.

7 May 2008

FDA approves Cimzia as treatment for Crohn's disease

A new drug has been approved to help sufferers of Crohn's disease, the U.S. Food and Drug Administration announced today. Cimzia (certolizumab pegol) received approval for adults with moderate to severe Crohn's disease who have not responded to conventional therapies. This product was approved with a Medication Guide.

22 Apr 2008

Boys are twice as likely as girls in the U.S. and Asia to receive growth hormone

Boys are twice as likely as girls in the U.S. and Asia (mostly Japan) to receive recombinant human growth hormone (rhGH) for growth hormone deficiency, illnesses that affect height, and short stature of a non-medical nature.

17 Apr 2008

Takeda to acquire Millennium for $8.8 billion

Takeda Pharmaceutical Company Limited and Millennium Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement pursuant to which Takeda will acquire Millennium for approximately $8.8 billion through a cash tender offer of $25.00 per share.

10 Apr 2008

Omega-3 fatty acids ineffective for managing Crohn's disease

An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

9 Apr 2008

Study identifies infection risks for patients with inflammatory bowel disease

A new Mayo Clinic study finds that patients who are 50 or older and take multiple immunosuppressive medications for inflammatory bowel disease have a higher risk for developing infections. The study is published in this month's issue of Gastroenterology.

3 Apr 2008

Potential new genetic markers for Crohn's disease

What is believed to be the largest study of its kind for the genetic roots of inflammatory bowel diseases has suggested new links to Crohn's Disease as well as further evidence that some people of Jewish descent are more likely to develop it.

28 Mar 2008

The effect of melatonin on colitis

In rats with experimental colitis, the marked increase in bacterial translocation in postcolitis rats has been reversed by melatonin administration.

19 Mar 2008

How do infections and toxins launch a cell's self-destruct and alarm system?

Cells are coded with several programs for self-destruction.

11 Mar 2008

Colon cancer treatment, symptoms, clinical trials

Fewer people are dying from colorectal cancer, but it remains the third deadliest form of cancer in America.

4 Mar 2008

Children's Hospital 1 of 10 pediatric hospitals in US selected to study liver disease in kids

Children's Hospital of Pittsburgh of UPMC has been selected to join an effort among select centers in the United States and Canada to collect and study information necessary to understand the possible causes and treatment of a destructive liver disease called primary sclerosing cholangitis (PSC).

27 Feb 2008

Quality of care for inflammatory bowel disease patients can be improved

Inflammatory bowel disease (IBD) is a chronic recurrent gastrointestinal disease.

26 Feb 2008

Scorpion venom may hold key to controlling cystic fibrosis

Researchers have discovered a peptide in scorpion venom that may hold the key to understanding and controlling cystic fibrosis and other secretory diseases.

17 Feb 2008

Discovery of possible target for prevention and treatment of pneumonia

Researchers at Children's Hospital of Pittsburgh of UPMC have identified a key protein target that may be a crucial factor in the development of a vaccine to prevent and new therapies to treat pneumonia, the leading killer of children worldwide.

12 Feb 2008

Potential new treatment for inflammatory bowel disease

Irish scientists have discovered a new potential therapeutic approach to Inflammatory Bowel Disease (IBD), a chronic debilitating disease involving inflammation of the intestine which affects more than 15,000 people in Ireland and millions of people worldwide.

15 Jan 2008

FDA approves Tysabri to treat Crohn's disease

The U.S. Food and Drug Administration has approved Tysabri (natalizumab) for the treatment of moderate-to-severe Crohn's disease in patients with evidence of inflammation who have had an inadequate response to, or are unable to tolerate, conventional Crohn's disease therapies.

14 Jan 2008

Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

New approach to treating autoimmune disease offered by Weizmann scientists

New genetic mutations involved in inflammatory intestinal disorders discovered

Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s

Tuberculosis not the only risk from new immunological drugs

Role of genetic components of dendritic cells could lead to more effective drugs

FDA approves Cimzia as treatment for Crohn's disease

Boys are twice as likely as girls in the U.S. and Asia to receive growth hormone

Takeda to acquire Millennium for $8.8 billion

Omega-3 fatty acids ineffective for managing Crohn's disease

Study identifies infection risks for patients with inflammatory bowel disease

Potential new genetic markers for Crohn's disease

The effect of melatonin on colitis

How do infections and toxins launch a cell's self-destruct and alarm system?

Colon cancer treatment, symptoms, clinical trials

Children's Hospital 1 of 10 pediatric hospitals in US selected to study liver disease in kids

Quality of care for inflammatory bowel disease patients can be improved

Scorpion venom may hold key to controlling cystic fibrosis

Discovery of possible target for prevention and treatment of pneumonia

Potential new treatment for inflammatory bowel disease

FDA approves Tysabri to treat Crohn's disease

The past, present and future of automation and digitalization in the life sciences laboratory

Arxspan BioDrive: A Versatile Solution for Molecular Biology

One Health, One Mission: The World Organisation for Animal Health on the AMR Frontline

Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

The past, present and future of automation and digitalization in the life sciences laboratory

Arxspan BioDrive: A Versatile Solution for Molecular Biology

One Health, One Mission: The World Organisation for Animal Health on the AMR Frontline

Newsletters you may be interested in